knowledge -WSS

knowledge

author：focus 2025-10-01 05:38:28 - browse：7

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： FDA scientists endorse Pfizer/BioNTech Covid

WSS

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Four alarming medical procedures we’re glad history forgot

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Multiple sclerosis has subtypes with different best treatments: study

Bird flu in dairy cattle: New measures to control spread to humans

Biotech startup Celsius cuts 75% of staff ahead of first trial start

focus

knowledge

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

Study: Black kids more likely to die after surgery than white kids

The high cost of giving birth even with insurance

Medicare slashes safety net hospital payments by nearly $1 billion

State Dept. review finds Biden bears some blame for Afghanistan failures

It costs an awful lot of money to give away a kidney

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA scientists endorse Pfizer/BioNTech Covid

Continuity nursing helped my family in our darkest PICU moments

When waiting feels immoral: Empathy in the emergency department

hotspot

First Opinion on colorectal cancer screening: letter and response

Covid silver lining: Unprecedented look at human immune system

U.K. decision on ALS drug has neurologists, advocates up in arms

A controversial new treatment promises to make little people taller

Four alarming medical procedures we’re glad history forgot

FDA scientists endorse Pfizer/BioNTech Covid

leisure time

knowledge

knowledge

leisure time